News & Resources

Stay up to date on our latest news

Filter by category:
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Announcement
Jul 15, 2026

Phase 2 clinical trial results for moxidectin in scabies to be presented at the 2026 AAD Innovation Academy

Announcement
Dec 11, 2024

Moxidectin approved in Ghana for the treatment of river blindness

Announcement
Oct 24, 2024

Recruitment into Phase 2b clinical trial for scabies complete

Announcement
Sep 30, 2024

Significant recruitment milestone achieved in scabies Phase 2 clinical trial

Announcement
Sep 30, 2024

Atticus to present at AusBioInvest meeting in Melbourne on October 29 2024

Announcement
Nov 28, 2023

Atticus Medical & Medicines Development for Global Health enrol first patient in Phase 2b study of moxidectin in scabies